Turning stats into outcomes
December 24, 2012
Members of the European Parliament (MEPs) have voted for more transparency and precise time limits to be set for pricing and reimbursement decisions on medicines.
July 18, 2012
US drugmakers have been taken aback by an appeal court's decision this week that "pay-for-delay" deals aimed at keeping generic competition off the market are anti-competitive.
April 16, 2012
South Africa's government is finalising a list of more than 70 medicines which must in future be procured from domestic manufacturers.
PharmaTimes 2013 Copyright | RSS Feed Subscriptions